SCHEMBL7410718

SCHEMBL7410718

CN(C(=O)C(CC1CCCCC1)NC(=O)c1ccc(Cl)cc1)C1(C#N)CCNCC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSS P25774 8/20 0.47
CTSL P07711 7/20 0.47
CTSB P07858 4/20 0.46
CTSK P43235 2/20 0.46
GRN P28799 2/20 0.43
SORT1 Q99523 2/20 0.43
PYGL P06737 1/20 0.39
CCKBR P32239 1/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37
POLB P06746 1/20 0.37
USP30 Q70CQ3 1/20 0.35
HTRA1 Q92743 1/20 0.35
CHRNB2 P17787 1/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
CHRNA4 P43681 1/20 0.35
GRIN1 Q05586 1/20 0.35
GRIN2A Q12879 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7417185 0.91 CTSL (0.57) CTSSCTSLCTSBCTSKGRN
SCHEMBL7409657 0.89 CTSS (0.60) CTSSCTSLCTSBCTSKGRN
SCHEMBL7414894 0.89 CTSS (0.45) CTSSCTSLCTSBCTSKGRN
SCHEMBL7414674 0.87 CTSS (0.45) CTSSCTSLCTSBCTSKKMT2A
SCHEMBL7026883 0.82 CTSS (0.52) CTSSCTSLCTSBCTSKKMT2A
SCHEMBL7414009 0.82 USP30 (0.46) CTSSCTSLCTSBCTSKKMT2A
SCHEMBL7419135 0.82 CTSS (0.45) CTSSCTSLCTSBCTSKGRN
SCHEMBL7415423 0.79 CTSS (0.43) CTSSCTSLCTSBCTSKGRN
SCHEMBL7414874 0.76 CTSS (0.46) CTSSCTSLCTSBCTSKUSP30
SCHEMBL5522964 0.74 CTSL (0.81) CTSSCTSLCTSBCTSKGRN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218372-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES Boehringer Ingelheim Pharmaceuticals, Inc. (US) 2002-07-03 EP disclosed
WO-2001019816-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2001-03-22 WO disclosed